Titlebook: Antimicrobial Drug Resistance; Clinical and Epidemi Douglas L. Mayers Book 2009 Humana Press 2009 Antimicrobial.Aspects.Clinical.Handbook.H

Graves’-disease

Mechanisms of Resistance in , and ,ant pathogens at breakpoints based on pharmacokinetic (PK) and pharmacodynamic (PD) parameters (2). The current status of resistance mechanisms found in . and . against the antimicrobial agents recommended for empiric and directed treatment of the diseases caused by these pathogens form the basis of this review.

非秘密

畢業(yè)典禮

Antibiotic Resistance of Anaerobic Bacteriassues. Treatment of anaerobic bacterial infection is complicated by the slow growth of these organisms, which makes diagnosis in the laboratory only possible after several days, by the often polymicrobial nature of the infection and by the growing resistance of anaerobic bacteria to antimicrobial agents.

責(zé)難

MITE

Antifungal Resistance: ,ised host defenses and in most cases, not considered to be due to drug resistant fungi. Also, failure of antifungal drugs may be due to inappropriate dose, fungistatic activity, high protein binding, poor absorption/ distribution and metabolism or drug interactions. Until recently, drug resistance in aspergillus was not adequately examined.

否認(rèn)

Book 2009 antimicrobial drug resistance that encompassed the current information available for bacteria, fungi, protozoa and viruses. We believe that this information will be of value to clinicians, epidemiologists, microbiologists, virologists, parasitologists, public health authorities, medical students an

Myosin

蒸發(fā)

Adj異類的

Enterococcus: Antimicrobial Resistance in Enterococci Epidemiology, Treatment, and Controlof these microorganisms is the gastrointestinal tract of human and other mammals, although they can be isolated from the oropharynx, female genital tract, and skin. Most recently, 36 species of enterococci have been described; however, 26 have been associated with human infection (2–4). . is the mos

exigent